Clostridial neurotoxins for treating uterine disorders

Details for Australian Patent Application No. 2004218467 (hide)

Owner Allergan, Inc.

Inventors Schiffman, Rhett M.

Agent Davies Collison Cave

Pub. Number AU-B-2004218467

PCT Pub. Number WO2004/078202

Priority 10/379,157 03.03.03 US

Filing date 25 February 2004

Wipo publication date 16 September 2004

Acceptance publication date 17 December 2009

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 21/02 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078202 Priority application(s): WO2004/078202

17 December 2009 Application Accepted

  Published as AU-B-2004218467

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218468-Method for increasing hair growth

2004218463-p38 inhibitors and methods of use thereof